Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-4673Fax+1 214-645-2661- Is this information wrong?
Education & Training
University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2005 - 2008
Creighton University School of MedicineClass of 2005
Certifications & Licensure
TX State Medical License 2009 - 2024
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Myelodysplastic Syndromes (MDS) Event Free Survival With Iron Chelation Therapy Study Start of enrollment: 2010 Mar 22
- Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) Start of enrollment: 2013 Dec 24
- Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA Start of enrollment: 2013 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Identifying patients at risk for hereditary myeloid malignancy syndromes incorporating a novel, self-administered questionnaire to an initial screening platform.Mohammad Faizan Zahid, Kelsey Moriarty, Courtney Dryden, Olga Weinberg, Misha Asif, Ruth Ikpefan, Julia M Anderson, Robert H Collins, Stephen S Chung, Weina Chen, Prap...> ;European Journal of Haematology. 2023 Dec 1
- Post-transplant cyclophosphamide and early mixed donor Chimerism in myeloid malignancies; a single-center experience.Fieke W Hoff, Stephen S Chung, Prapti A Patel, Naveen Premnath, Jude Khatib, Mirjana Tadic-Ovcina, Abeer AhmedRabie, Debra Helton, Selamawit Yohannes, Jaime Shahan, He...> ;Transplant Immunology. 2023 Apr 1
- 4 citationsDisabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance.Junhua Lyu, Yuxuan Liu, Lihu Gong, Mingyi Chen, Yazan F Madanat, Yuannyu Zhang, Feng Cai, Zhimin Gu, Hui Cao, Pranita Kaphle, Yoon Jung Kim, Fatma N Kalkan, Helen Step...> ;Cancer Discovery. 2023 Jan 9
- Join now to see all
Abstracts/Posters
- Precision Medicine Treatment in Older AML: Results of Beat AML Master TrialClinically Relevant AbstractPrapti A. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Pharmacokinetic Exposure Equivalence and Preliminary Efficacy and Safety from a Randomized Cross over Phase 3 Study (ASCERTAIN study) of an Oral Hypomethylating Agent ...Prapti A. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Newly Diagnosed AML Patient Samples Demonstrate High Degree of Concordance in Identification of Pathogenic Mutations By Next Generation Sequencing (NGS) Performed at E...Prapti A. Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
Dr. Patel on the Role of Gilteritinib in FLT3+ AMLFebruary 17th, 2020- Targeted Therapy Shifts AML Paradigm, but More Work Lies AheadJanuary 28th, 2020
Hospital Affiliations
University of Texas Southwestern Medical CenterDallas, Texas
William P. Clements, Jr. University HospitalDallas, Texas- Dallas Medical CenterDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
